Norman L. Letvin US-amerikanischer Immunologe und AIDS-Forscher
Letvin, Norman L.
Letvin, Norman
Letvin, N.L.
VIAF ID: 9911510 (Personal)
Permalink: http://viaf.org/viaf/9911510
Preferred Forms
- 200 _ | ‡a Letvin ‡b Norman
-
-
- 100 1 _ ‡a Letvin, N.L.
- 100 1 _ ‡a Letvin, Norman
-
-
- 100 1 _ ‡a Letvin, Norman L.
- 100 1 0 ‡a Letvin, Norman L.
-
- 100 0 _ ‡a Norman L. Letvin ‡c US-amerikanischer Immunologe und AIDS-Forscher
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Cytotoxic T cells in HIV and other retroviral infections, 1992: | |
Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes. | |
Reconnaissance de variants d'un épitope viral par des lymphocytes T CD8+ induits par la vaccination de singes rhésus | |
Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells | |
Simian immunodeficiency virus | |
Simian models for AIDS. | |
The SIVmac specific cytotoxic T lymphocyte response in the acutely infected rhesus monkey. | |
Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens | |
Strategies for an HIV vaccine | |
Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes | |
Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection | |
Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo | |
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. | |
Syrian hamsters express diverse MHC class I gene products | |
Systemic vaccination induces clonally diverse SIV-specific CD8+ T-cell populations in systemic and mucosal compartments | |
T-cell dynamics during acute SIV infection. | |
T lymphocyte immunity to reovirus: cellular requirements for generation and role in clearance of primary infections | |
T lymphocyte surface antigens in primates | |
TCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in Mamu-A*01+ rhesus monkeys | |
The TCR repertoire of an immunodominant CD8+ T lymphocyte population | |
The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance | |
Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes | |
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques | |
Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques | |
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination | |
Transcriptional network predicts viral set point during acute HIV-1 infection | |
Transmission of naturally occurring lymphoma in macaque monkeys | |
Understanding the basis of CD4 | |
Unusually limited nucleotide sequence variation of the expressed major histocompatibility complex class I genes of a New World primate species (Saguinus oedipus) | |
Use of an anti-CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques. | |
Use of cDNA probes specific for the human MHC class II beta loci for tissue-typing nonhuman primates at their class II beta loci | |
Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines | |
Use of radiolabeled monoclonal anti-B1 antibody for B lymphocyte imaging in rhesus monkeys | |
Utility of SHIV for testing HIV-1 vaccine candidates in macaques. | |
Vaccination of mice and nonhuman primates using HIV-gene-containing DNA | |
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates | |
Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. | |
Vaccine-elicited systemic and mucosal humoral responses of lactating rhesus monkeys vaccinated with the transmitted/founder HIV Envelope 1086C. | |
Vaccine-induced CD8+ T lymphocytes of rhesus monkeys recognize variant forms of an HIV epitope but do not mediate optimal functional activity. | |
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 | |
Variability in a dominant block to SIV early reverse transcription in rhesus monkey cells predicts in vivo viral replication and time to death | |
Variable NKG2 expression in the peripheral blood lymphocytes of rhesus monkeys | |
Vgamma2Vdelta2+ T cells and anti-microbial immune responses | |
Viral evolution and challenges in the development of HIV vaccines | |
Virology. Moving forward in HIV vaccine development | |
Virus-specific cellular immune correlates of survival in vaccinated monkeys after SIV challenge | |
What immunity can protect against HIV infection |